transfollicular nanovaccine (Vindico)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug Nametransfollicular nanovaccine (Vindico)
Drug Alias Namepolymersome-based LACK + resiquimod nanovaccine (Vindico)
ClassificationVaccines > Development/production technology > Inactivated vaccine > Subunit vaccineVaccines > Application > Prophylactic vaccine
Mechanisms of ActionToll like receptor 7 agonistsToll like receptor 8 agonists
TargetsToll like receptor 8Toll like receptor 7
Therapy Area/IndicationsLeishmaniasis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesVindico Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesVindico Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsLeishmaniasis

Other Information

ATC CodeN/A
Related LinksN/A